Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/connect-biopharma-enhances-its-intellectual-property-estate-for-cbp-307-a-targeted-therapy-with-potential-in-multiple-autoimmune-diseases-with-patent-issuances-in-the-united-states-eu-japan-and-australia-301010279.html
https://www.prnewswire.com/news-releases/connect-biopharma-reports-positive-topline-data-from-moderate-to-severe-atopic-dermatitis-ad-phase-1b-study-of-cbp-201-300983333.html
https://www.prnewswire.com/news-releases/connect-biopharma-reports-positive-topline-data-from-moderate-to-severe-atopic-dermatitis-ad-phase-1b-study-of-cbp-201-300983333.html
https://www.prnewswire.com/news-releases/connect-biopharma-reports-positive-topline-data-from-moderate-to-severe-atopic-dermatitis-ad-phase-1b-study-of-cbp-201-300983333.html